Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

Cited by (1,004)

Items 801–900 of 1,004

1. Clinical risk factors for mortality in patients with cancer and COVID-19: a systematic review and meta-analysis of recent observational studies
   Liu Yang, Huan Lu, Wei Wang, Qi Liu, Changju Zhu · 2020 · Expert Review of Anticancer Therapy
2. Declines in Mortality Over Time for Critically Ill Adults With Coronavirus Disease 2019
   Sara C. Auld, Mark E. Caridi-Scheible, Chad J. Robichaux, Craig M. Coopersmith, David J. Murphy · 2020 · Critical Care Medicine
3. Men and COVID-19: A Pathophysiologic Review
   Martin Stephen Lipsky, Man Hung · 2020 · American Journal of Men s Health
4. Remdesivir Treatment for Severe COVID-19 in Third-Trimester Pregnancy: Case Report and Management Discussion
   Grace A. Maldarelli, Megan Savage, Shawn Mazur, Corrina M. Oxford-Horrey, Mirella Salvatore, Kristen Marks · 2020 · Open Forum Infectious Diseases
5. Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID-19 infection
   Martin J Burton, Jan Clarkson, Beatriz Goulão, Anne‐Marie Glenny, Andrew J. McBain, Anne GM Schilder, Katie E Webster, Helen V Worthington · 2020 · Cochrane Database of Systematic Reviews
6. A Low-Producing Haplotype of Interleukin-6 Disrupting CTCF Binding Is Protective against Severe COVID-19
   Tao Chen, Yuxin Lin, Yan Zha, Ying Hao Sun, Jinxiu Tian, Zhiying Yang, Shanwen Lin, Fuxun Yu, Zi‐Sheng Chen, Bo‐Hua Kuang et al. · 2021 · mBio
7. Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia
   Daya Ram Parajuli, Saval Khanal, Kannikar Hannah Wechkunanukul, Saurav Ghimire, Arjun Poudel · 2021 · Research in Social and Administrative Pharmacy
8. Intravenous methylprednisolone with or without tocilizumab in patients with severe COVID-19 pneumonia requiring oxygen support: A prospective comparison
   Dujana Mostafa Hamed, Khawla Mohammad Belhoul, Naama Abdelrahman Al Maazmi, Ghayoor Farah, Muneeba Moin, Mahra Al Suwaidi, Meeruna Narainen, Maryam Makki, Mahera Abdulrahman · 2021 · Journal of Infection and Public Health
9. Simultaneous Bilateral Central Retinal Artery Occlusion following COVID-19 Infection
   Maneesh M. Bapaye, A. Nair, Charuta M Bapaye · 2021 · Ocular immunology and inflammation
10. Therapeutic Application of Alpha-1 Antitrypsin in COVID-19
    Felix Ritzmann, Praneeth Chitirala, Yiwen Yao, Nadine Krüger, Markus Hoffmann, Wei Zuo, Frank Lammert, Sigrun Smola, Nastasja Seiwert, Naveh Tov et al. · 2021 · American Journal of Respiratory and Critical Care Medicine
11. Risk Factors for Severe Outcomes in Patients With Systemic Vasculitis and COVID‐19: A Binational, Registry‐Based Cohort Study
    Matthew A. Rutherford, Jennifer Scott, Maira Karabayas, Marilina Antonelou, Seerapani Gopaluni, David Gray, Joe Barrett, Silke R. Brix, Neeraj Dhaun, Stephen Paul McAdoo et al. · 2021 · Arthritis & Rheumatology
12. Are Some COVID-19 Vaccines Better Than Others? Interpreting and Comparing Estimates of Efficacy in Vaccine Trials
    Rekha R. Rapaka, Elizabeth Adrianne Hammershaimb, Kathleen Maletic Neuzil · 2021 · Clinical Infectious Diseases
13. Corticosteroids and tocilizumab reduce in-hospital mortality in severe COVID-19 pneumonia: a retrospective study in a Spanish hospital
    Eva Van den Eynde, Oriol Gasch, Joan Carles Oliva, Emilio García-Prieto, Sònia Calzado, Aina Gomila Grange, María Luisa Machado, Luis Falgueras, S Ortonobes Roig, Anisi Morón et al. · 2021 · Scandinavian Journal of Infectious Diseases
14. Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider
    Alessia Alunno, Aurélie Najm, Xavier Mariette A, Gabriele De Marco, Jenny Emmel, Laura Mason, Dennis McGonagle, Pedro Machado · 2021 · Annals of the Rheumatic Diseases
15. Network Meta‐Analysis on the Mechanisms Underlying Alcohol Augmentation of COVID‐19 Pathologies
    Wenfei Huang, Heping Zhou, Colin A. Hodgkinson, Angelo Montero, David A Goldman, Sulie L. Chang · 2021 · Alcoholism Clinical and Experimental Research
16. SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
    Gisela Canedo-Marroquín, Farides Saavedra, Catalina A. Andrade, Roslye V. Berríos-Rojas, Linmar Rodríguez‐Guilarte, María Cecilia Opazo, Claudia A. Riedel, Alexis M. Kalergis · 2020 · Frontiers in Immunology
17. A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19
    Suresh Kumar, Rosemarie de Souza, Milind Nadkar, Randeep Guleria, Anjan Trikha, Shashank Joshi, Subramanian Loganathan, Sivakumar Vaidyanathan, Ashwani Marwah, Sandeep N. Athalye · 2021 · Expert Opinion on Biological Therapy
18. Case Report: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Relapse With COVID-19
    M. Woodhall, James W. Mitchell, E. Gibbons · 2020 · Frontiers in Neurology
19. IDentif . AI : Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐Cov‐2) with digital drug development
    Agata Blasiak, Jhin Jieh Lim, Shirley G. K. Seah, Theodore Wonpeum Kee, Alexandria Remus, De Hoe Chye, Pui San Wong, Lissa Hooi, Anh T. L. Truong, Nguyen Le et al. · 2020 · Bioengineering & Translational Medicine
20. Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art
    Yinhua Zhang, Yuanyuan Chen, Zhongji Meng · 2020 · Frontiers in Immunology
21. Mechanisms of COVID‐19‐induced cardiovascular disease: Is sepsis or exosome the missing link?
    Mallikarjun Patil, Sarojini Singh, John Henderson, Prasanna Krishnamurthy · 2020 · Journal of Cellular Physiology
22. Putative invasive pulmonary aspergillosis in critically ill patients with COVID‐19: An observational study from New York City
    Hayato Mitaka, David C. Perlman, Waleed Javaid, Nadim Salomon · 2020 · Mycoses
23. Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility
    Flavia Biamonte, Cirino Botta, Maria Mazzitelli, Salvatore Rotundo, Enrico Maria Trecarichi, DANIELA PATRIZIA FOTI, Carlo Torti, Giuseppe Viglietto, Daniele Torella, Francesco Saverio Costanzo · 2021 · Journal of Translational Medicine
24. Acute Kidney Injury in COVID-19: The Chinese Experience
    Xizi Zheng, Youlu Zhao, Yang Li · 2020 · Seminars in Nephrology
25. Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats
    Carlos Chaccour, Gloria Abizanda, Ángel Irigoyen Barrio, Aina Casellas, Azucena Aldaz, Fernando Martinez, Felix Hammann, Ana Gloria Gil · 2020 · Scientific Reports
26. Clinical management of COVID-19: Experiences of the COVID-19 epidemic from Groote Schuur Hospital, Cape Town, South Africa
    Marc Mendelson, Linda Boloko, Adam Boutall, Lydia L. Cairncross, Greg Calligaro, C Coccia, Joel Alex Dave, M De Villiers, Sipho Kenneth Dlamini, P Frankenfeld et al. · 2020 · South African Medical Journal
27. Combating COVID-19: Lessons learnt particularly among developing countries and the implications
    Brian Godman · 2020 · Bangladesh Journal of Medical Science
28. Current Effective Therapeutics in Management of COVID-19
    Kavya Atluri, I. Aimlin, S. Arora · 2022 · Journal of Clinical Medicine
29. Low Levels of Few Micronutrients May Impact COVID-19 Disease Progression: An Observational Study on the First Wave
    Teresa Maria Tomasa-Irriguible, Lara Bielsa-Berrocal, Maria Luisa Bordeje-Laguna, Cristina Tural, Jaume Barallat, Josep Maria Manresa‐Domínguez, Pere Torán‐Monserrat · 2021 · Metabolites
30. Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19
    Charles R. Vasquez, Shruti Gupta, Todd A. Miano, Meaghan Roche, Jesse Y. Hsu, Wei Cheng Yang, Daniel N. Holena, John P. Reilly, Sarah J. Schrauben, David E. Leaf et al. · 2021 · CHEST Journal
31. The Management of Immunosuppression in Kidney Transplant Recipients with COVID-19 Disease: An Update and Systematic Review of the Literature
    R. Angelico, F. Blasi, T. Manzia · 2021 · Medicina
32. Visual lung damage CT score at hospital admission of COVID-19 patients and 30-day mortality
    Etienne Charpentier, Gilles Soulat, Antoine Fayol, A. Hernigou, Marine Livrozet, Téodor Grand, Guillaume Reverdito, Jad al Haddad, K. Dang Tran, Anne Charpentier et al. · 2021 · European Radiology
33. Hypoxia and viral infectious diseases
    Richard Huang, Melissa Huestis, Esther Shuyi Gan, Eng Eong Ooi, Michael Ohh · 2021 · JCI Insight
34. Application of microbial 3-ketosteroid Δ1-dehydrogenases in biotechnology
    Ali Rohman, Bauke W. Dijkstra · 2021 · Biotechnology Advances
35. The role of antirheumatics in patients with COVID-19
    Christoffer B Nissen, Savino Sciascia, DANIELI CASTRO OLIVEIRA DE ANDRADE, Tatsuya Atsumi, Ian N Bruce, Randy Quentin Cron, Oliver Hendricks, Dario Roccatello, Ksenija Stach, Mattia Trunfio et al. · 2021 · The Lancet Rheumatology
36. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study
    Shaji Sebastian, G Walker, Nicholas Alexander Kennedy, Thomas Edward Conley, Kamal Patel, Sreedhar Subramanian, Alexandra J. Kent, Jonathan Philip Segal, Matthew Brookes, Neeraj B. Bhala et al. · 2021 · The Lancet. Gastroenterology & hepatology
37. SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease
    Kristin M. D’Silva, Naomi J. Serling-Boyd, Tiffany Y. T. Hsu, Jeffrey A. Sparks, Zachary Scott Wallace · 2021 · Annals of the Rheumatic Diseases
38. Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study
    Ismael Francisco Aomar Millán, Juan Salvatierra, Úrsula Torres-Parejo, Naya Faro‐Míguez, José Luís Callejas-Rubio, Ángel Ceballos-Torres, María Teresa Cruces-Moreno, Francisco Javier Gómez-Jiménez, José Hernández‐Quero, Francisco Anguita-Santos et al. · 2021 · Internal and Emergency Medicine
39. The impact of viremia on organ failure, biomarkers and mortality in a Swedish cohort of critically ill COVID-19 patients
    Josef D. Järhult, Michael Hultström, Anders Bergqvist, Robert Frithiof, Miklós Lipcsey · 2021 · Scientific Reports
40. Anti-COVID-19 efficacy of ivermectin in the golden hamster
    G. D. de Melo, F. Lazarini, F. Larrous et al. · 2020 · bioRxiv
41. Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations
    Dalia M. Dawoud, Khaled Y. Soliman · 2020 · Value in Health
42. Teaching Old Drugs New Tricks: Statins for COVID-19?
    David C. Fajgenbaum, Daniel James Rader · 2020 · Cell Metabolism
43. Blood nitrate and nitrite modulating nitric oxide bioavailability: Potential therapeutic functions in COVID-19
    Hideo Yamasaki · 2020 · Nitric Oxide
44. Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19
    Lars M. König, Daniel F. R. Boehmer, Philipp Metzger, Max M. Schnurr, Stefan Endres, Simon Rothenfußer · 2020 · The Journal of Experimental Medicine
45. Pyruvate affects inflammatory responses of macrophages during influenza A virus infection
    Hazar Abusalamah, Jessica Morgan Reel, Christopher R. Lupfer · 2020 · Virus Research
46. Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide
    Abdulla A.‐B. Badawy · 2020 · Bioscience Reports
47. Use of IFNγ/IL10 Ratio for Stratification of Hydrocortisone Therapy in Patients With Septic Shock
    Rainer König, Amol Kolte, Olaf Ahlers, Marcus Oswald, Veiko Krauss, Daniela Roell, Oliver Sommerfeld, George Dimοpoulos, Iraklis Tsangaris, Eleni Antoniadou et al. · 2021 · Frontiers in Immunology
48. RETRACTED: Clinical and Scientific Rationale for the “MATH+” Hospital Treatment Protocol for COVID-19
    Kory, Pierre, Meduri, G. Umberto, Iglesias, Jose, Varon, Joseph, Marik, Paul E. · 2021 · Journal of Intensive Care Medicine · Retracted
49. Early steroids and ventilator-associated pneumonia in COVID-19-related ARDS
    Pauline Lamouche-Wilquin, Jérôme Souchard, Morgane Peré et al. · 2022 · Critical Care
50. Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy
    Yusri Taha, Hayley Wardle, Adam B. Evans, Ewan Hunter, Helen J. Marr, Wendy Osborne, Matthew Bashton, Darren Smith, Shirelle Burton-Fanning, Matthias Ludwig Schmid et al. · 2021 · Annals of Clinical Microbiology and Antimicrobials
51. The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial
    M. Ghanei, M. Solaymani-Dodaran, Ali Qazvini et al. · 2021 · Respiratory Research
52. COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study
    Luca Saverio Belli, Christophe Duvoux, Paolo Angelo Cortesi, Rita Facchetti, Speranţa Iacob, Giovanni Perricone, Sylvie Radenne, Sara Conti, Damiano Patrono, Gabriela A Berlakovich et al. · 2021 · Gut
53. Management of COVID-19: current status and future prospects
    M. Kabir, R. Ahmed, R. Chowdhury, S. M. Iqbal, R. Paulmurugan, U. Demirci, W. Asghar · 2021 · Microbes and infection
54. Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial
    Vincent Dubée, P. Roy, B. Vielle et al. · 2021 · Clinical Microbiology and Infection
55. Cardiac surgery outcome during the COVID-19 pandemic: a retrospective review of the early experience in nine UK centres
    Julie Sanders, Enoch Akowuah, Jackie A. Cooper, Bilal H. Kirmani, Mazyar Kanani, Metesh Acharya, Reuben Jeganathan, George Krasopoulos, Dumbor Laateh Ngaage, Indu Deglurkar et al. · 2021 · Journal of Cardiothoracic Surgery
56. Systematic screening for COVID‐19 associated invasive aspergillosis in ICU patients by culture and PCR on tracheal aspirate
    Rebecca van Grootveld, Judith van Paassen, Mark G. J. de Boer, Eric C. J. Claas, Ed J. Kuijper, Martha T. van der Beek · 2021 · Mycoses
57. How Many Intensive Care Beds are Justifiable for Hospital Pandemic Preparedness? A Cost-effectiveness Analysis for COVID-19 in Germany
    Afschin Gandjour · 2021 · Applied Health Economics and Health Policy
58. Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial
    Chuan-Bo Li, Feng-Ming Luo, Chengwu Liu et al. · 2021 · Annals medicus
59. Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2
    Biering, Scott B., Van Dis, Erik, Wehri, Eddie, Yamashiro, Livia H., Wrynla, Xammy Huu, Dugast-Darzacq, Claire, Graham, Thomas G. W., Stroumza, Julien R., Golovkine, Guillaume R., Roberts, Allison W. et al. · 2021 · ACS Infectious Diseases
60. Validation of Inflammopathic, Adaptive, and Coagulopathic Sepsis Endotypes in Coronavirus Disease 2019
    Timothy E. Sweeney, Oliver Liesenfeld, James W. Wacker, Yudong D. He, David Rawling, Melissa Remmel, Sabrina Coyle, Uros Midic, Antigone Kotsaki, Aggeliki Kanavou et al. · 2020 · Critical Care Medicine
61. Anti-Inflammatory Effects of Amantadine and Memantine: Possible Therapeutics for the Treatment of Covid-19?
    F. Jiménez-Jiménez, H. Alonso-Navarro, E. García-Martín · 2020 · Journal of Personalized Medicine
62. Corticosteroids in severe COVID-19: a critical view of the evidence
    Daniel De Backer, Élie Azoulay, Jean‐Louis Vincent · 2020 · Critical Care
63. Acute Respiratory Distress Syndrome
    George W. Williams, Nathaniel K. Berg, Alexander Reskallah, Xiaoyi Yuan, Holger K. Eltzschig · 2020 · Anesthesiology
64. Computational insight of dexamethasone against potential targets of SARS-CoV-2
    Adewale Oluwaseun Fadaka, Nicole Remaliah Samantha Sibuyi, Abram Madimabe Madiehe, Mervin Meyer · 2020 · Journal of Biomolecular Structure and Dynamics
65. Critically Ill Patients with COVID-19: A Narrative Review on Prone Position
    Syeda Kashfi Qadri, Priscilla Ng, Theresa S. W. Toh, Sin Wee Loh, Herng Lee Tan, Cheryl Lin, Eddy Fan, Jan Hau Lee · 2020 · Pulmonary Therapy
66. COVID-19 Pandemic and Children: A Review
    Vinay Rathore, Abhiruchi Galhotra, Rahul Pal, Kamal Kant Sahu · 2020 · The Journal of Pediatric Pharmacology and Therapeutics
67. Comparison of deep learning with regression analysis in creating predictive models for SARS-CoV-2 outcomes
    Ahmed Abdulaal, Aatish M. Patel, Esmita Charani, Sarah Denny, Saleh A. Alqahtani, Gary Davies, Nabeela Mughal, Luke S. P. Moore · 2020 · BMC Medical Informatics and Decision Making
68. Widespread testing, case isolation and contact tracing may allow safe school reopening with continued moderate physical distancing: A modeling analysis of King County, WA data
    Chloe Bracis, Eileen Burns, Mia Moore, David A. Swan, Daniel B. Reeves, Joshua Tisdell Schiffer, Dobromir Dimitrov · 2020 · Infectious Disease Modelling
69. Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist
    Antonio Martínez‐López, Carlos Cuenca‐Barrales, Trinidad Montero‐Vílchez, Alejandro Molina‐Leyva, Salvador Arias‐Santiago · 2020 · Journal of the American Academy of Dermatology
70. Mining of high throughput screening database reveals AP-1 and autophagy pathways as potential targets for COVID-19 therapeutics
    Hu Zhu, Catherine Z. Chen, Srilatha Sakamuru, Jinghua Zhao, Deborah K. Ngan, Anton M. Simeonov, Mathew D. Hall, Menghang Xia, Wei Zheng, Ruili Huang · 2021 · Scientific Reports
71. Uric acid as a prognostic factor and critical marker of COVID-19
    Gang Li, Xia Wu, Chen-Liang Zhou · 2021 · Scientific Reports
72. COVID-19 and acute exacerbation of interstitial lung disease
    Yasuhiro Kondoh, Kensuke Kataoka, Masaru Ando, Yukikazu Awaya, Kazuya Ichikado, Mikio Kataoka, Yuko Komase, Masamichi Mineshita, Yasushi Ohno, Hiroaki Okamoto et al. · 2021 · Respiratory Investigation
73. Potential role of IFN-α in COVID-19 patients and its underlying treatment options
    Lei Yang, Jian-Hui Wang, Pei Hui · 2021 · Applied Microbiology and Biotechnology
74. COVID-19 in solid organ transplant recipients: A national cohort study from Sweden
    J. M. Søfteland, G. Friman, B. von zur Mühlen et al. · 2021 · American Journal of Transplantation
75. Impact of early corticosteroids on 60-day mortality in critically ill patients with COVID-19: A multicenter cohort study of the OUTCOMEREA network
    Claire Dupuis, Étienne de Montmollin, Niccolò Buetti, Dany Goldgran-Tolédano, Jean Reignier, Carole Schwebel, Julien Domitile, Mathilde Neuville, Moreno Ursino, Shidasp Siami et al. · 2021 · PLoS ONE
76. Molecular mechanisms of Na,K-ATPase dysregulation driving alveolar epithelial barrier failure in severe COVID-19
    Vitalii Kryvenko, István Vadász · 2021 · American Journal of Physiology-Lung Cellular and Molecular Physiology
77. Vitamin D3 to Treat COVID-19
    David E. Leaf, Adit A. Ginde · 2021 · JAMA
78. Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19
    Ulrich Hofstadt-van Oy, S. Stankovic, C. Kelbel · 2021 · Journal of Neurology
79. Diabetes predicts severity of COVID‐19 infection in a retrospective cohort: A mediatory role of the inflammatory biomarker C‐reactive protein
    Huilin Koh, Angela Mei Chung Moh, Ester Chai Kheng Yeoh, Yi Lin, Serena Kiat Mun Low, Say Tat Ooi, Seng Kiong Tan, Jaime Hui Xian Lin, Caroline Wei Shan Hoong · 2021 · Journal of Medical Virology
80. Research in forced displacement: guidance for a feminist and decolonial approach
    Neha S. Singh, Michelle Lokot, Chi-Chi Undie · 2021 · The Lancet
81. Serum Prealbumin Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis
    Angelo Zinellu, Arduino Aleksander Mangoni · 2021 · Frontiers in Medicine
82. Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis
    Rimesh Pal, Mainak Banerjee, Soham Mukherjee, Ranjitpal Singh Bhogal, Amanpreet Kaur, Sanjay Kumar Bhadada · 2021 · Therapeutic Advances in Endocrinology and Metabolism
83. Changes in Availability, Utilization, and Prices of Medicines and Protection Equipment for COVID-19 in an Urban Population of Northern Nigeria
    Mainul Haque, Abdullahi Rabiu Abubakar, Olayinka O. Ogunleye, Ibrahim Haruna Sani, Israel Abebrese Sefah, Amanj Baker Kurdi, Salequl Islam, Brian Godman · 2021 · Journal of Research in Pharmacy Practice
84. Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic
    Giulio Cavalli, Nicola Farina, Corrado Campochiaro, Giacomo Davide De Luca, Emanuel Della‐Torre, Alessandro Tomelleri, Lorenzo Dagna · 2020 · Frontiers in Pharmacology
85. Repurposing Anti-Cancer Drugs for COVID-19 Treatment
    Nicholas C. Borcherding, Yogesh S. Jethava, Praveen Vikas · 2020 · Drug Design Development and Therapy
86. Prognostic factors and predictors of outcome in patients with COVID-19 and related pneumonia: a retrospective cohort study
    Gianluca E.M. Boari, Giulia Chiarini, Silvia Bonetti, Paolo Malerba, Gianluca Bianco, Cristina Faustini, Federico Braglia-Orlandini, Daniele Turini, Vittoria Guarinoni, Michele Saottini et al. · 2020 · Bioscience Reports
87. Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia
    A. D’Alessio, P. Del Poggio, Federico Bracchi, G. Cesana, N. Sertori, Daniela Di Mauro, A. Fargnoli, M. Motta, C. Giussani, P. Moro et al. · 2020 · Leukemia
88. Hydroxychloroquine versus Azithromycin for Hospitalized Patients with COVID-19. Results of a Randomized, Active Comparator Trial
    Samuel Morris Brown, Ithan D. Peltan, Naresh P. Kumar, Lindsay M. Leither, Brandon J. Webb, Nathan J. Starr, Colin K. Grissom, Whitney R. Buckel, Rajendu Srivastava, Allison M. Butler et al. · 2020 · Annals of the American Thoracic Society
89. Repurposed Drugs, Molecular Vaccines, Immune‐Modulators, and Nanotherapeutics to Treat and Prevent COVID‐19 Associated with SARS‐CoV‐2, a Deadly Nanovector
    Taru Dube, Amrito Ghosh, Jibanananda Mishra, Uday B. Kompella, Jiban Jyoti Panda · 2020 · Advanced Therapeutics
90. SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment
    Khalil Khalaf, Natalia Papp, Jadzia Tin-Tsen Chou, Doris Hana, Andrzej Adam Mackiewicz, Mariusz Kaczmarek · 2020 · Frontiers in Immunology
91. Case Report: COVID-19 Associated Renal Infarction and Ascending Aortic Thrombosis
    Aveek Mukherjee, Raisa Ghosh, Marlene Marte Furment · 2020 · American Journal of Tropical Medicine and Hygiene
92. Efficacy and Safety of Corticosteroid Treatment in Patients With COVID-19: A Systematic Review and Meta-Analysis
    Wenwen Cheng, Yufeng Li, Yan Cui, Ying Chen, Sharui Shan, Duan Xiao, Xiaoyun Chen, Zhuoming Chen, Anding Xu · 2020 · Frontiers in Pharmacology
93. Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses
    Patrick O’Connell, Yasser Ali Aldhamen · 2020 · Human Vaccines & Immunotherapeutics
94. Include pregnant women in research—particularly covid-19 research
    M. Knight, R. K. Morris, J. Furniss · 2020 · British medical journal
95. Multidisciplinary Guidance Regarding the Use of Immunomodulatory Therapies for Acute Coronavirus Disease 2019 in Pediatric Patients
    Daniel E. Dulek, Robert C. Fuhlbrigge, Alison C. Tribble, James Albert Connelly, Michele M. Loi, Hassan El Chebib, Shanmuganathan Chandrakasan, William R Otto, Caroline J. Diorio, Garrett P. Keim et al. · 2020 · Journal of the Pediatric Infectious Diseases Society
96. The impact of type 2 diabetes and its management on the prognosis of patients with severe COVID ‐19
    Zihui Xu, Zhongjing Wang, Shuo Wang, Yingchun Ye, Deng Luo, Li Wan, Ailin Yu, Lifang Sun, Solomon Hailemariam Tesfaye, Qingtao Meng et al. · 2020 · Journal of Diabetes
97. Clinical characteristics and survival analysis in critical and non-critical patients with COVID-19 in Wuhan, China: a single-center retrospective case control study
    Ran Tian, Wei Wu, Chunyao Wang, Haiyu Pang, Zhiyu Zhang, Haopeng Xu, Qingfeng Luo, Peng Gao, Jihua Shi, Wenbin Li et al. · 2020 · Scientific Reports
98. Pharmacokinetics-Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: a Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents
    Markus Alexander Zeitlinger, Birgit C. P. Koch, Roger J. M. Brüggemann, Pieter A. J. G. De Cock, Tim Felton, Maya Hites, Jennifer Lê, Sònia Luque, Alasdair P. MacGowan, Deborah J. E. Marriott et al. · 2020 · Clinical Pharmacokinetics
99. Corticosteroids for treatment of COVID-19: effect, evidence, expectation and extent
    Vijay K. Patel, Ekta Shirbhate, Preeti Patel, Ravichandran Veerasamy, Prabodh Chander Sharma, Harish Rajak · 2021 · Beni-Suef University Journal of Basic and Applied Sciences
100. LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes
     Ícaro Bonyek-Silva, A. Machado, T. Cerqueira-Silva et al. · 2021 · Diabetes